|
1
|
Modrek B and Lee C: A genomic view of
alternative splicing. Nat Genet. 30:13–19. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Johnson JM, Castle J, Garrett-Engele P,
Kan Z, Loerch PM, Armour CD, Santos R, Schadt EE, Stoughton R and
Shoemaker DD: Genome-wide survey of human alternative pre-mRNA
splicing with exon junction microarrays. Science. 302:2141–2144.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Resch A, Xing Y, Modrek B, Gorlick M,
Riley R and Lee C: Assessing the impact of alternative splicing on
domain interactions in the human proteome. J Proteome Res. 3:76–83.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sorek R, Shamir R and Ast G: How prevalent
is functional alternative splicing in the human genome? Trends
Genet. 20:68–71. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Baldwin RM, Morettin A and Côté J: Role of
PRMTs in cancer: Could minor isoforms be leaving a mark? World J
Biol Chem. 5:115–129. 2014.PubMed/NCBI
|
|
6
|
Yang Y and Bedford MT: Protein arginine
methyltransferases and cancer. Nat Rev Cancer. 13:37–50. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Herrmann F, Pably P, Eckerich C, Bedford
MT and Fackelmayer FO: Human protein arginine methyltransferases in
vivo - distinct properties of eight canonical members of the PRMT
family. J Cell Sci. 122:667–677. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lakowski TM and Frankel A: Kinetic
analysis of human protein arginine N-methyltransferase 2: Formation
of monomethyl- and asymmetric dimethyl-arginine residues on histone
H4. Biochem J. 421:253–261. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Besson V, Brault V, Duchon A, Togbe D,
Bizot JC, Quesniaux VF, Ryffel B and Hérault Y: Modeling the
monosomy for the telomeric part of human chromosome 21 reveals
haploinsufficient genes modulating the inflammatory and airway
responses. Hum Mol Genet. 16:2040–2052. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Blythe SA, Cha SW, Tadjuidje E, Heasman J
and Klein PS: beta-Catenin primes organizer gene expression by
recruiting a histone H3 arginine 8 methyltransferase, Prmt2. Dev
Cell. 19:220–231. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ganesh L, Yoshimoto T, Moorthy NC, Akahata
W, Boehm M, Nabel EG and Nabel GJ: Protein methyltransferase 2
inhibits NF-kappaB function and promotes apoptosis. Mol Cell Biol.
26:3864–3874. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Iwasaki H, Kovacic JC, Olive M, Beers JK,
Yoshimoto T, Crook MF, Tonelli LH and Nabel EG: Disruption of
protein arginine N-methyltransferase 2 regulates leptin
signaling and produces leanness in vivo through loss of STAT3
methylation. Circ Res. 107:992–1001. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yildirim AO, Bulau P, Zakrzewicz D,
Kitowska KE, Weissmann N, Grimminger F, Morty RE and Eickelberg O:
Increased protein arginine methylation in chronic hypoxia: Role of
protein arginine methyltransferases. Am J Respir Cell Mol Biol.
35:436–443. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhong J, Cao RX, Zu XY, Hong T, Yang J,
Liu L, Xiao XH, Ding WJ, Zhao Q, Liu JH, et al: Identification and
characterization of novel spliced variants of PRMT2 in breast
carcinoma. FEBS J. 279:316–335. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhong J, Cao RX, Liu JH, Liu YB, Wang J,
Liu LP, Chen YJ, Yang J, Zhang QH, Wu Y, et al: Nuclear loss of
protein arginine N-methyltransferase 2 in breast carcinoma is
associated with tumor grade and overexpression of cyclin D1
protein. Oncogene. 33:5546–5558. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin WJ, Gary JD, Yang MC, Clarke S and
Herschman HR: The mammalian immediate-early TIS21 protein and the
leukemia-associated BTG1 protein interact with a protein-arginine
N-methyltransferase. J Biol Chem. 271:15034–15044. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen SL, Loffler KA, Chen D, Stallcup MR
and Muscat GEO: The coactivator-associated arginine
methyltransferase is necessary for muscle differentiation: CARM1
coactivates myocyte enhancer factor-2. J Biol Chem. 277:4324–4333.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Torres-Padilla ME, Parfitt DE, Kouzarides
T and Zernicka-Goetz M: Histone arginine methylation regulates
pluripotency in the early mouse embryo. Nature. 445:214–218. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
McBride AE and Silver PA: State of the
arg: Protein methylation at arginine comes of age. Cell. 106:5–8.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lukong KE and Richard S: Arginine
methylation signals mRNA export. Nat Struct Mol Biol. 11:914–915.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Meister G and Fischer U: Assisted RNP
assembly: SMN and PRMT5 complexes cooperate in the formation of
spliceosomal UsnRNPs. EMBO J. 21:5853–5863. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li H, Park S, Kilburn B, Jelinek MA,
Henschen-Edman A, Aswad DW, Stallcup MR and Laird-Offringa IA:
Lipopolysaccharide-induced methylation of HuR, an mRNA-stabilizing
protein, by CARM1. Coactivator-associated arginine
methyltransferase. J Biol Chem. 277:44623–44630. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang B, Dong S, Li Z, Lu L, Zhang S, Chen
X, Cen X and Wu Y: Targeting protein arginine methyltransferase 5
inhibits human hepatocellular carcinoma growth via the
downregulation of beta-catenin. J Transl Med. 13:3492015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Goulet I, Gauvin G, Boisvenue S and Côté
J: Alternative splicing yields protein arginine methyltransferase 1
isoforms with distinct activity, substrate specificity, and
subcellular localization. J Biol Chem. 282:33009–33021. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
El Messaoudi S, Fabbrizio E, Rodriguez C,
Chuchana P, Fauquier L, Cheng D, Theillet C, Vandel L, Bedford MT
and Sardet C: Coactivator-associated arginine methyltransferase 1
(CARM1) is a positive regulator of the Cyclin E1 gene. Proc
Natl Acad Sci USA. 103:13351–13356. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Thomassen M, Tan Q and Kruse TA: Gene
expression meta-analysis identifies chromosomal regions and
candidate genes involved in breast cancer metastasis. Breast Cancer
Res Treat. 113:239–249. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Baldwin RM, Morettin A, Paris G, Goulet I
and Côté J: Alternatively spliced protein arginine
methyltransferase 1 isoform PRMT1v2 promotes the survival and
invasiveness of breast cancer cells. Cell Cycle. 11:4597–4612.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhong J, Cao RX, Hong T, Yang J, Zu XY,
Xiao XH, Liu JH and Wen GB: Identification and expression analysis
of a novel transcript of the human PRMT2 gene resulted from
alternative polyadenylation in breast cancer. Gene. 487:1–9. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ohkura N, Takahashi M, Yaguchi H, Nagamura
Y and Tsukada T: Coactivator-associated arginine methyltransferase
1, CARM1, affects pre-mRNA splicing in an isoform-specific manner.
J Biol Chem. 280:28927–28935. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gros L, Renodon-Cornière A, de Saint
Vincent BR, Feder M, Bujnicki JM and Jacquemin-Sablon A:
Characterization of prmt7alpha and beta isozymes from Chinese
hamster cells sensitive and resistant to topoisomerase II
inhibitors. Biochim Biophys Acta. 1760:1646–1656. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yoshimoto T, Boehm M, Olive M, Crook MF,
San H, Langenickel T and Nabel EG: The arginine methyltransferase
PRMT2 binds RB and regulates E2F function. Exp Cell Res.
312:2040–2053. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Meyer R, Wolf SS and Obendorf M: PRMT2, a
member of the protein arginine methyltransferase family, is a
coactivator of the androgen receptor. J Steroid Biochem Mol Biol.
107:1–14. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tashiro E, Tsuchiya A and Imoto M:
Functions of cyclin D1 as an oncogene and regulation of cyclin D1
expression. Cancer Sci. 98:629–635. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim JK and Diehl JA: Nuclear cyclin D1: An
oncogenic driver in human cancer. J Cell Physiol. 220:292–296.
2009. View Article : Google Scholar : PubMed/NCBI
|
